MedPath

UROLOGY OF VIRGINIA

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
http://www.urologyofva.net/

Clinical Trials

3

Active:0
Completed:2

Trial Phases

2 Phases

Phase 3:1
Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (66.7%)
Phase 3
1 (33.3%)

Liposomal Bupivacaine To Control Post-Operative Pain Following BMG

Phase 3
Completed
Conditions
Urethral Stricture
Interventions
First Posted Date
2018-10-25
Last Posted Date
2021-10-01
Lead Sponsor
Urology of Virginia
Target Recruit Count
50
Registration Number
NCT03720223
Locations
🇺🇸

Urology of Virginia, Virginia Beach, Virginia, United States

Initiation of Androgen Deprivation Therapy for Prostate Cancer Using Degarelix Followed by Leuprolide

Not Applicable
Completed
Conditions
Prostate Cancer
Interventions
First Posted Date
2011-04-29
Last Posted Date
2013-03-18
Lead Sponsor
Urology of Virginia
Target Recruit Count
50
Registration Number
NCT01344564
Locations
🇺🇸

Urology of Virginia, Virginia Beach, Virginia, United States

Dutasteride for Improving Peri-Operative and Long-Term Outcomes of Photoselective Vaporization of the Prostate (DOP)

Not Applicable
Conditions
Benign Prostatic Hyperplasia
Lower Urinary Tract Symptoms
First Posted Date
2006-01-10
Last Posted Date
2007-04-18
Lead Sponsor
Urology of Virginia
Target Recruit Count
60
Registration Number
NCT00274417
Locations
🇺🇸

Urology of Virginia, Virginia Beach, Virginia, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.